News: Molecular Biosciences

Most antibodies against SARS-CoV-2 circulating in the blood target areas of the viral spike protein outside the receptor binding domain, or RBD

Four drugs used to treat hepatitis C render remdesivir 10 times better at inhibiting the coronavirus in cell cultures.

A COVID-19 vaccine in human trials in Vietnam, Thailand and Brazil, holds promise for affordable vaccine manufacturing in countries currently dependent on imported vaccines.

Gene editing inside living cells could become more effective and accurate after researchers unveiled how inner workings can help or hinder the process.

The Welch Foundation announced that Ilya J. Finkelstein who has been researching the coronavirus and the gene-editing tool CRISPR, will receive the 2021 Norman Hackerman Award...

​Carlos Baiz, Caroline Morley, Andrew Potter and Urbain Weyemi are among the 128 scholars from across the country selected by the Alfred P. Sloan Foundation to receive the 2021 Sloan...

Undergraduates at the UT Austin Inventors Program are exploring how mealworms, and the microbes in their guts, can naturally degrade household plastics.

For the first time, scientists identified a critical mechanism that remdesivir uses against SARS-CoV-2 and unearthed information that drug companies can use to develop new...

See the new faces at the College of Natural Sciences.